Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-28T05:47:58.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-21T02:00:46.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The government funding/operating status banner has been removed from the page, removing ancillary status notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-13T22:34:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Results have been posted and the study status shows Completed, with enrollment and completion dates updated accordingly.
    Difference
    0.4%
    Check dated 2025-10-30T13:09:15.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Major update: adds a government-status notice and the new software version v3.2.0, replaces the old v3.0.2.
    Difference
    3%
    Check dated 2025-10-02T01:28:49.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T14:19:06.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.